Pioglitazone was associated with lower risk for adverse cardiovascular events than rosiglitazone in older patients

Commentary

Ananda Basu

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
JournalAnnals of Internal Medicine
Volume152
Issue number4
StatePublished - Feb 16 2010

Fingerprint

rosiglitazone
pioglitazone

ASJC Scopus subject areas

  • Internal Medicine

Cite this

@article{3678d6634e324d02a9ff0790867d5993,
title = "Pioglitazone was associated with lower risk for adverse cardiovascular events than rosiglitazone in older patients: Commentary",
author = "Ananda Basu",
year = "2010",
month = "2",
day = "16",
language = "English (US)",
volume = "152",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "4",

}

TY - JOUR

T1 - Pioglitazone was associated with lower risk for adverse cardiovascular events than rosiglitazone in older patients

T2 - Commentary

AU - Basu, Ananda

PY - 2010/2/16

Y1 - 2010/2/16

UR - http://www.scopus.com/inward/record.url?scp=77952563713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952563713&partnerID=8YFLogxK

M3 - Article

VL - 152

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 4

ER -